Literature DB >> 28126879

Prevention of complications in type 2 diabetes: is drug glucose control evidence based?

Rémy Boussageon1, Denis Pouchain2, Vincent Renard3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28126879      PMCID： PMC5308113          DOI： 10.3399/bjgp17X689317

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  14 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 3.  Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?

Authors:  T Bejan-Angoulvant; C Cornu; P Archambault; B Tudrej; P Audier; Y Brabant; F Gueyffier; R Boussageon
Journal:  Diabetes Metab       Date:  2015-05-06       Impact factor: 6.041

Review 4.  Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?

Authors:  R Boussageon; F Gueyffier; C Cornu
Journal:  Diabetes Metab       Date:  2014-02-03       Impact factor: 6.041

5.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

6.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

7.  Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

Authors:  J W J Beulens; A Patel; J R Vingerling; J K Cruickshank; A D Hughes; A Stanton; J Lu; S A McG Thom; D E Grobbee; R P Stolk
Journal:  Diabetologia       Date:  2009-07-25       Impact factor: 10.122

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 9.  Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Authors:  Bianca Hemmingsen; Søren S Lund; Christian Gluud; Allan Vaag; Thomas Almdal; Christina Hemmingsen; Jørn Wetterslev
Journal:  BMJ       Date:  2011-11-24

10.  Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

Authors:  Rémy Boussageon; Irène Supper; Theodora Bejan-Angoulvant; Nadir Kellou; Michel Cucherat; Jean-Pierre Boissel; Behrouz Kassai; Alain Moreau; François Gueyffier; Catherine Cornu
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069
View more
  6 in total

1.  The wrong paradigm may be driving drug glucose control in the face of the evidence.

Authors:  Craig A McArthur
Journal:  Br J Gen Pract       Date:  2017-04       Impact factor: 5.386

2.  Using Patient Health Profile Evaluation for Predicting the Likelihood of Retinopathy in Patients with Type 2 Diabetes: A Cross-Sectional Study Using Latent Profile Analysis.

Authors:  Shang-Jyh Chiou; Kuomeng Liao; Kuan-Chia Lin; Wender Lin
Journal:  Int J Environ Res Public Health       Date:  2022-05-17       Impact factor: 4.614

3.  Prevalence of type 2 diabetes and their complications among home health care patients at Al-Kharj military industries corporation hospital.

Authors:  Mohammed Albarakat; Ali Guzu
Journal:  J Family Med Prim Care       Date:  2019-10-31

4.  One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitus.

Authors:  Ashok K Das; Sanjay Kalra; Shashank Joshi; Ambrish Mithal; Prasanna Kumar K M; Ambika G Unnikrishnan; Hemant Thacker; Bipin Sethi; Subhankar Chowdhury; Romik Ghosh; Sukanya Krishnan; Arjun Nair; Senthilnathan Mohanasundaram; Shalini K Menon; Vaibhav Salvi; Deepa Chodankar; Saket Thaker; Chirag Trivedi; Subhash K Wangnoo; Abdul H Zargar; Nadeem Rais
Journal:  Endocrinol Diabetes Metab       Date:  2021-12-01

5.  Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home.

Authors:  Kimberly R Azelton; Aidan P Crowley; Nicholas Vence; Karin Underwood; Gerald Morris; John Kelly; Matthew J Landry
Journal:  Front Digit Health       Date:  2021-11-25

Review 6.  Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials.

Authors:  Christina Baechle; Wiebke Scherler; Alexander Lang; Tim Filla; Oliver Kuss
Journal:  Acta Diabetol       Date:  2022-05-09       Impact factor: 4.087
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.